Stay updated on Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial

Sign up to get notified when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s site footer version was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a general platform release without changing the study record content.
    Difference
    0.0%
    Check dated 2026-04-26T15:18:05.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T12:49:43.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now lists 44 locations for the study; the detailed site list has been trimmed. Revision: v3.5.0 is displayed on the page.
    Difference
    4%
    Check dated 2026-03-21T07:55:33.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Version update: added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T18:29:15.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Version label updated from v3.4.1 to v3.4.2 in the page footer.
    Difference
    0.0%
    Check dated 2026-02-13T07:37:07.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added a Lancet HIV 2021 96-week results publication citation with revision note (v3.4.1) and removed the Lancet HIV erratum reference with revision (v3.4.0).
    Difference
    0.0%
    Check dated 2026-02-05T14:20:57.000Z thumbnail image

Stay in the know with updates to Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.